A 48-year-old man with treatment-resistant depression has been switched from fluoxetine to venlafaxine XR 225 mg daily. After 3 weeks, he develops severe headache, neck stiffness, tremor, hyperreflexia, and agitation. His core temperature is 38.5°C. He admits to taking an herbal supplement containing St. John's wort for 2 weeks alongside the venlafaxine. What is the most likely diagnosis and the primary mechanism of toxicity?

Explanation

## Diagnosis: Serotonin Syndrome ### Clinical Presentation (Hunter Criteria) This patient meets diagnostic criteria for serotonin syndrome: **Neuromuscular signs:** - Hyperreflexia (exaggerated deep tendon reflexes) - Tremor - Rigidity (implied by neck stiffness) **Autonomic instability:** - Fever (38.5°C) - Tachycardia (likely) **Mental status changes:** - Agitation - Confusion **Key Point:** Serotonin syndrome is a **pharmacological overdose** of serotonin — not a true allergy or idiosyncratic reaction. It occurs when serotonergic activity exceeds the brain's capacity to regulate it. ### Mechanism: Synergistic Serotonergic Toxicity **High-Yield:** Venlafaxine + St. John's wort = **dual serotonin elevation** 1. **Venlafaxine (SNRI)**: Inhibits reuptake of serotonin AND norepinephrine at the presynaptic terminal - At 225 mg XR, this is a high dose with potent SERT inhibition 2. **St. John's wort (Hypericum perforatum)**: - Also inhibits serotonin reuptake (weak SSRI-like activity) - Induces CYP3A4 and CYP2C9 → increases venlafaxine metabolism - BUT also has direct serotonergic effects - **Paradoxically increases serotonin levels** despite inducing venlafaxine metabolism 3. **Net result**: Excessive synaptic serotonin → overstimulation of 5-HT~1A~, 5-HT~1B~, 5-HT~2A~, and 5-HT~7~ receptors → clinical syndrome ### Pathophysiology of Serotonin Syndrome ```mermaid flowchart TD A[Venlafaxine 225 mg XR + St. John's wort]:::action --> B[Inhibition of SERT<br/>Serotonin reuptake blocked]:::outcome B --> C[Increased synaptic serotonin]:::outcome C --> D{Receptor overstimulation}:::decision D -->|5-HT1A/1B| E[Tremor, hyperreflexia<br/>Neuromuscular rigidity]:::outcome D -->|5-HT2A| F[Hyperthermia, agitation<br/>Autonomic instability]:::outcome D -->|5-HT7| G[Altered mental status<br/>Confusion, disorientation]:::outcome E --> H[SEROTONIN SYNDROME]:::urgent F --> H G --> H ``` ### Severity Grading | Severity | Features | Management | | --- | --- | --- | | **Mild** | Tremor, hyperreflexia, mydriasis, GI upset | Observation, supportive care | | **Moderate** | Above + agitation, muscle rigidity, fever <39°C | Discontinue serotonergic agent, benzodiazepines, IV fluids | | **Severe** | Rigidity, hyperthermia >40°C, rhabdomyolysis, DIC, altered mental status | **ICU admission, aggressive cooling, cyproheptadine (5-HT antagonist)** | **This patient is MODERATE–SEVERE** and requires immediate intervention. ### Management 1. **Immediate**: Discontinue venlafaxine AND St. John's wort 2. **Supportive**: IV fluids, cooling measures, benzodiazepines (lorazepam) for agitation 3. **Pharmacological**: Cyproheptadine (non-selective 5-HT antagonist) - Loading: 12 mg PO/NG - Maintenance: 2 mg every 2 hours × 24 hours, then 4–8 mg TID 4. **Monitoring**: CK, electrolytes, urine myoglobin (rhabdomyolysis risk) **Clinical Pearl:** Cyproheptadine is the only FDA-approved specific treatment for serotonin syndrome. It blocks 5-HT~1A~, 5-HT~1B~, 5-HT~2A~, and has anticholinergic effects that also help with autonomic symptoms. ### Why Not the Other Options? **Option 0 (Neuroleptic malignant syndrome):** NMS is caused by dopamine antagonism (antipsychotics, metoclopramide). Venlafaxine has no dopamine-blocking activity. NMS also typically requires antipsychotic exposure and has a longer onset (24–72 hours). The acute presentation (3 weeks) with a serotonergic drug combination points to serotonin syndrome, not NMS. **Option 2 (Anticholinergic toxidrome):** Anticholinergic toxicity causes "hot as a hare, dry as a bone, red as a beet, mad as a hatter" — mydriasis, dry skin, flushed skin, tachycardia, and confusion. Venlafaxine has minimal anticholinergic activity. Hyperreflexia and neck stiffness are NOT anticholinergic features; they are serotonergic. **Option 3 (Meningitis):** While meningitis presents with fever and neck stiffness, it would show CSF pleocytosis (elevated WBC, protein), low glucose, and positive culture/PCR. The tremor, hyperreflexia, and temporal relationship to drug initiation strongly favor serotonin syndrome. Meningitis is a clinical mimic but requires CSF analysis to exclude. ### High-Yield: Drug Combinations That Cause Serotonin Syndrome | Combination | Risk Level | Notes | | --- | --- | --- | | SSRI/SNRI + MAOI | **CONTRAINDICATED** | Absolute contraindication; 2-week washout required | | SSRI/SNRI + Tramadol | High | Tramadol inhibits reuptake + releases serotonin | | SSRI/SNRI + St. John's wort | High | Both increase synaptic serotonin | | SSRI/SNRI + Linezolid | Moderate–High | Linezolid is a weak MAOI | | SSRI/SNRI + Dextromethorphan | Moderate | DXM has serotonergic activity | | SSRI/SNRI + 5-HTP or L-tryptophan | Moderate | Substrate for serotonin synthesis | **Mnemonic for serotonin syndrome triggers:** **"SERT MAOI TRAM"** - **S**SRIS/SNRIs - **E**rgot alkaloids - **R**eversal agents (linezolid) - **T**ramadol, TCAs - **M**AO inhibitors - **O**ther serotonergics (5-HTP, St. John's wort) - **I**nteractions (dextromethorphan, sympathomimetics)